Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

InstaRISPACS / InstaZFP / InstaMobi v5.0

K-Number: K182572 · 2019-04-12

Decision Date2019-04-12
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

InstaRISPACS / InstaZFP / InstaMobi v5.0 is a medical device manufactured by Meddiff Technologies Pvt. , Ltd.. It received FDA 510(k) clearance on 2019-04-12 under approval number K182572. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the InstaRISPACS / InstaZFP / InstaMobi v5.0?

InstaRISPACS / InstaZFP / InstaMobi v5.0 is a medical device that received FDA 510(k) clearance on 2019-04-12. It is manufactured by Meddiff Technologies Pvt. , Ltd.. The 510(k) number is K182572.

When was InstaRISPACS / InstaZFP / InstaMobi v5.0 approved by the FDA?

InstaRISPACS / InstaZFP / InstaMobi v5.0 received FDA 510(k) clearance on 2019-04-12, under approval number K182572.

What company makes InstaRISPACS / InstaZFP / InstaMobi v5.0?

InstaRISPACS / InstaZFP / InstaMobi v5.0 is manufactured by Meddiff Technologies Pvt. , Ltd..

What is the FDA product code for InstaRISPACS / InstaZFP / InstaMobi v5.0?

The FDA product code for InstaRISPACS / InstaZFP / InstaMobi v5.0 is LLZ.

Related Devices (Code: LLZ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.